A Blind, Randomized and Controlled Clinical Trial to Evaluate the Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccines for Healthy Children
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Varicella zoster vaccine Sinovac Biotech (Primary)
- Indications Varicella zoster virus infections
- Focus Therapeutic Use
- Sponsors Sinovac (Dalian) Vaccine Technology
- 24 Oct 2017 Status changed from active, no longer recruiting to completed.
- 25 Sep 2017 Results presented in a Sinovac Biotech media release.
- 28 Nov 2016 According to a Sinovac Biotech media release, the company expects to complete this trial in the third quarter of 2017.